David Cotter, MD, PhD, FAAD
SESSIONS
DISCLOSURES
AbbVie – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Fees), Speaker(Honoraria); Alumis – Advisory Board(Honoraria); Arcutis Biotherapeutics – Speaker(Honoraria); Blueprint Medicines – Advisory Board(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Bristol Myers Squibb – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Castle Biosciences – Investigator(Fees), Speaker(Honoraria), Speaker/Faculty Education(Honoraria); DermTech Inc. – Speaker(Honoraria); Eli Lilly – Advisory Board(Honoraria); Galderma – Speaker(Honoraria); Incyte – Advisory Board(Honoraria); Johnson and Johnson – Advisory Board(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria), Investigator(Fees), Speaker(Honoraria); Novartis – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Organon – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Regeneron – Investigator(Fees); Sanofi/Regeneron – Speaker(Honoraria); Thermo Fischer Scientific – Investigator(Fees); UCB – Advisory Board(Honoraria); Veradermics – Consultant (1099 relationship)(Honoraria);